Hello, everyone. I welcome you to the presentation of Prodways Group results. I'm Michaël Ohana, CEO of Prodways Group, and I'm here with our CFO, Laurent Cardin, to present our first first half results of the year. I will start with a few comments on the activity, which will be followed by a presentation of the financial results by Laurent, and I will conclude with some comments on our perspectives. As usual, we'll leave some time for a question and answer session at the end of the presentation. So let's start with the key figures. Prodways Group generated 31 million EUR of revenue in the first half. That is -4% versus last year on a comparable basis. This performance is a bit disappointing, but still correct in the context of operational changes and restructuring plans. The second quarter concluded a transition period, paving the way for revenue growth in the second half of 2024. The EBITDA margin stands at 8%, still below the group's expectations, but improving four points since the second half of last year. This is a sign that the measures we are taking to improve our performance are giving results. The cash generated from operations remains positive despite the numerous changes we implemented since the start of the year. Prodways maintains a healthy financial discipline. Just a quick reminder for those who have recently discovered us about the structure of our offer. We are structured into two divisions: the system divisions, where we provide our customers who wish to produce 3D parts on their own with printers, materials, and software to design their parts. The product divisions, where we offer all customers who wish to have high level, varied, and high quality printing parts produced for them. We have simplified this division early 2024, with the disposal of our Cristal brand, which was not strategic for the group, and is now composed of digital manufacturing and 3D audiology business. We are a fully integrated player with a complete offer and possessing advanced skill across the entire 3D printed value chain. Let's now move on to the presentation of our activity, starting with the systems division. We announced early 2024 that we decided to refocus our printers activity on the industrial segment and discontinue the jewelry application. The sales of these small printers generated a turnover of around 5 million EUR in 2023 and a significant operating loss. This operation is now finalized. The cost was smaller than anticipated, below EUR 800,000, thanks to the sale of some assets of the activity. This operation allow us to improve the cash generation of the group by around EUR 2.5 million on an annual basis. Our objective is to focus on the segment of large, high value added printers and associated 3D materials, in particular, the MovingLight range. In addition to the orthodontics application, we had our first success with our new ceramic printer with a large aerospace company. The performance of this activity is, as usual, supported by the recurring sales of 3D materials. They remain a strong contributor to the profitability of the group. The second contributor to results in systems division is the 3D software activity, where we have been deploying our new sales and marketing organizations since last year. These efforts are proving relevant this semester. The profitability of this activity is driving the results upwards with an EBITDA margin above 15%. The transition towards the SaaS model is still ongoing and well managed. Its main benefit is the increase of the recurring revenue of the group. Overall, the systems divisions performed relatively well in this first half, despite many changes in the organization. Revenues are stable on a comparable basis, and the EBITDA margin stands at 13%. The products division had a challenging first half. The reorganization of the production and the new sales strategy had some impacts on generation of revenues. Many actions are on the way to address these issues and come back to a positive dynamic. They concern mainly the process of impression taking in the audiology activity and the industrial productivity in our manufacturing sites. In figures for the products division, the revenues decreased by 8% on a comparable basis. As a consequence, the profitability is below expectations, with an EBITDA margin of 6%. This is clearly a disappointing performance, but with the actions underway, the group is aiming for stronger results in the second half of this year. I now leave the floor to Laurent to comment the financial results. Thank you, Michaël. Good evening, everybody. I will start with a few comments on the P&L for H1 2024. Revenue stand at EUR 31 million. The decrease compared to last year is largely explained by three changes, representing EUR 10.6 million. The first one, the change in IFRS classification in the software activity since July 2023, which we commented during the full year result 2023. The discontinuation of the jewelry activity, and at last, the disposal of Cristal Dental Lab. On a comparable basis, revenues are down EUR 1.4 million, that is minus 4%, due to the product division performance, as already commented by Michaël. EBITDA margin is three points lower than last year. It is impacted by the last negative contribution of the jewelry activity in Q1 2024, and by the lower revenues. After D&A, the income for ordinary activities stand at EUR 1.2 million. The financial results and tax items were small this semester, with some positive effects offsetting the cost of debt and corporate tax. Net income, therefore, stands at EUR 1.3 million. Concerning the cash generation, Prodways Group generated EUR 2.5 million of cash from operations, a good level relative to EBITDA. The working capital increased by around 1 million, with the usual seasonality of the first half in the software activity. It will improve in the second half. CapEx were fairly limited, with EUR 600,000 invested this semester. Overall, Prodways maintain a healthy financial discipline. The group had EUR 13 million of cash available at the end of June and a net debt of EUR 3.8 million. I now let Michaël conclude on the perspectives. Thank you, Laurent. Now, let's move on to the outlook. With the many changes realized in the past months, Prodways is now in a better condition to improve its results. With the effect of the refocusing of some activities and reorganizations, the headcount is now largely reduced by around one hundred people compared to end of 2023. This will allow us to decrease our cost and to improve our EBITDA margin of around three million on a yearly basis. Thanks to these efforts, our efforts to increase revenues in the short and medium terms should therefore translate into stronger cash flows, and this should start in 2024. Our objective for this year is to generate more revenue on a comparable basis between +1% and +5%, with a higher EBITDA margin. This means that we aim for better results in the second half of this year. I want to thank you for listening, and like usual, we will now leave some time for questions and answers. Thank you. Thank you very much, sir. Ladies and gentlemen, if you'd like to ask an audio question, please press star one on your telephone keypad. Also, just make sure your mute function is not activated in order to just reach your equipment. So that's star one for audio questions. Our first question today is coming from Aurélien Sibileau of Oddo. Please go ahead. Hi, good afternoon. Thanks a lot for taking my question. The first one, I believe you previously indicated between €4 million and €5 million of cost savings on a yearly basis. And my question is: Are you still on track to reach this range? And can you maybe remind us the expected split between two thousand and twenty-four fiscal year and two thousand and twenty-five? So, yes, I will answer part of this and maybe let Laurent complete, if needed. Clearly, we are on track with the plan we communicated. So yes, you're completely right. Between twenty twenty-four and twenty twenty-five, during the two years, we expected a cost reduction of about EUR 4-5 million, and this is still the case. Now, the split you are asking certainly between what will happen this year compared to next year. Maybe, Laurent, you have a rough estimation about what will be this year and what will be in twenty twenty-five? Roughly half and half, in terms of reduction. It will be half and half, so around 2.5 each year to reach this plan, which is completely online. Okay. Okay, very clear. I don't see the next question. I don't see any one-off cost recorded in H1 at all, unless I'm wrong. And so should we consider some one-off to be recorded in H2? ... Take this one? Yeah, yeah. All the one-off? All the one-off costs are in the P&L for this semester. The impact of some sales and the disposal of Cristal, for instance, compensate this one-off cost, and the main part for sure. We had the provision last year at the end of two thousand twenty-four. Everything is in the- Twenty-three. Twenty-three, pardon, so 2023, yes. Everything is in the P&L at the end of June. Okay. So basically, no more one-off, or at least, very small number in H2. Nothing behind us. Can you hear me? Yes. Yes. Okay. My question was about CapEx and D&A. I think it decreased quite a lot in H1 versus H2 last year, or H1 last year, so I understand that it is related to some R&D projects, so maybe can you give us more color on what kind of projects have been postponed or even stopped? Again, this is linked to the jewelry discontinuation, mainly. At the end of two thousand and twenty-three, we amortized all the project that will not be continued in the future. So the main reason of the decrease in amortization is due to this jewelry discontinuation plan that we implement last year. But- Okay ... in terms of R&D, we are still on the same way than we when we used to. Okay, very clear. Thank you very much. Thank you for your question. Thank you, Mr. Sibi. We have no further audio questions at this time. Okay. And also, what it appears that we have no further audio question, written or audio questions, gentlemen, so I'd like to turn the call back over to you for any additional or closing remarks. Thank you. So we have some written questions, so I will take the first one and read it from Clement from Portzamparc. "Why the EBITDA decreased by 10% on product?" And the question is not only due to revenue, but also issue in manufacturing. So the question is good, but in fact, you answered in your own question. The reason is mainly due to revenue, revenue decrease, and particularly on the audiology business division, which is in products, where we had issues, not manufacturing, but on the impression taking of the customer. Now, it's an operation that has to be made on the field, because the beauty of our offer is that it's an on-demand specific product adapted to the customer itself. So we have to go there physically and to take the impression taking. And we had problems of organization at the beginning of the year, in order to split all the good person on the field, and this is completely solved now. We also lacked some technicians, which were also now recruited and trained. So to answer this question, the impact is only on revenue and no issues in manufacturing. Regarding the second question and the third- Yes ... and the third one, I think that we already answered. It's about D&A decreased by 46%, while your revenue decreased by 21%. This is due to the jewelry discontinuation I explained just before. And no more exceptional spending related to the reorganization, as mentioned. Our everything is on the P&L at the end of June, and we expect no additional one-off cost. There is also still a question from Clement. Is there exceptional spending related to the reorganization, so the answer is no. This was done during H1. This was behind us, and now the company is ready for the next semester to be more effective in terms of profitability, and also with the pipeline we see, some new revenue will come very quickly, so we think we have no other questions, so we thank you all for your participation, and hope to see you soon for the next communication of Prodways Group. Thank you very much. Thank you.